These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12134782)

  • 1. Impact of moderate aerobic exercise training on insulin sensitivity in type 2 diabetic men treated with oral hypoglycemic agents: is insulin sensitivity enhanced only in non-obese subjects?
    Bense L
    Med Sci Monit; 2002 Jun; 8(6):LE23; discussion L24. PubMed ID: 12134782
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of moderate aerobic exercise training on insulin sensitivity in type 2 diabetic men treated with oral hypoglycemic agents: is insulin sensitivity enhanced only in nonobese subjects?
    Poirier P; Tremblay A; Broderick T; Catellier C; Tancrède G; Nadeau A
    Med Sci Monit; 2002 Feb; 8(2):CR59-65. PubMed ID: 11859274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients.
    Lucotti P; Setola E; Monti LD; Galluccio E; Costa S; Sandoli EP; Fermo I; Rabaiotti G; Gatti R; Piatti P
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E906-12. PubMed ID: 16772327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective treatments for insulin resistance: trim the fat and douse the fire.
    Evans JL; Youngren JF; Goldfine ID
    Trends Endocrinol Metab; 2004 Nov; 15(9):425-31. PubMed ID: 15519889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glimepiride pharmacokinetics in obese versus non-obese diabetic patients.
    Shukla UA; Chi EM; Lehr KH
    Ann Pharmacother; 2004 Jan; 38(1):30-5. PubMed ID: 14742789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D; Nyström T
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients.
    Ballani P; Tran MT; Navar MD; Davidson MB
    Diabetes Care; 2006 Nov; 29(11):2504-5. PubMed ID: 17065692
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin treatment and the problem of weight gain in type 2 diabetes.
    Carver C
    Diabetes Educ; 2006; 32(6):910-7. PubMed ID: 17102158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA; Kane MP; Busch RS
    Pharmacotherapy; 2007 Oct; 27(10):1449-55. PubMed ID: 17896900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance.
    Ruan H; Pownall HJ
    Curr Opin Investig Drugs; 2009 Apr; 10(4):346-52. PubMed ID: 19337955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiating insulin in type 2 diabetes mellitus: there's no rush.
    Cohen Y
    Isr Med Assoc J; 2004 May; 6(5):294-5. PubMed ID: 15151372
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum level of retinol-binding protein 4 in obese patients with insulin resistance and in patients with type 2 diabetes treated with metformin].
    Tajtáková M; Semanová Z; Ivancová G; Petrovicová J; Donicová V; Zemberová E
    Vnitr Lek; 2007 Sep; 53(9):960-3. PubMed ID: 18019665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents.
    Hanyu O; Miida T; Kosuge K; Ito T; Soda S; Hirayama S; Wardaningsih E; Fueki Y; Obayashi K; Aizawa Y
    Clin Chim Acta; 2007 Sep; 384(1-2):118-23. PubMed ID: 17651713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Approach to diabetes therapy. 2. Selection and the use of oral antidiabetics. 2) Agents to correct insulin resistance].
    Kashiwagi A; Maegawa H
    Nihon Naika Gakkai Zasshi; 2000 Aug; 89(8):1530-5. PubMed ID: 11062900
    [No Abstract]   [Full Text] [Related]  

  • 15. Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients.
    De Feyter HM; Praet SF; van den Broek NM; Kuipers H; Stehouwer CD; Nicolay K; Prompers JJ; van Loon LJ
    Diabetes Care; 2007 Oct; 30(10):2511-3. PubMed ID: 17626892
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of acute starvation on insulin resistance in obese patients with and without type 2 diabetes mellitus.
    Duska F; Andel M; Kubena A; Macdonald IA
    Clin Nutr; 2005 Dec; 24(6):1056-64. PubMed ID: 16185788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of type 2 diabetes mellitus with oral antihyperglycaemic therapy.
    Desai A; Tandon N
    Natl Med J India; 2007; 20(4):192-8. PubMed ID: 18085125
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of dynamic strength training on insulin sensitivity in men with insulin resistance].
    Hejnová J; Majercík M; Polák J; Richterová B; Crampes F; deGlisezinski I; Stich V
    Cas Lek Cesk; 2004; 143(11):762-5. PubMed ID: 15628572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes mellitus in childhood: obesity and insulin resistance.
    Schwartz MS; Chadha A
    J Am Osteopath Assoc; 2008 Sep; 108(9):518-24. PubMed ID: 18806081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with new targets in Type 2 diabetes: a review of available agents with a focus on pre-exercise adjustment.
    McDonnell ME
    J Cardiopulm Rehabil Prev; 2007; 27(4):193-201. PubMed ID: 17667012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.